Our free daily oncology focused e-news service.
Subscribe» | Search Archives»
(Reuters Health) June 18, 2013 - Studies that are funded by pharmaceutical companies or involve industry-backed scientists tend to be more prominent at cancer meetings than independent studies, a new report suggests.
read article »
(Reuters) June 17, 2013 - Antibodies to a high-risk type of a virus that causes mouth and throat cancers when transmitted via oral sex can be detected in blood tests many years before onset of the disease, according to a World Health Organisation-led team of researchers.
read article »
(Dana-Farber) June 17, 2013 - Dana-Farber researchers find many men with low-risk, localized prostate cancers can safely choose observation instead of undergoing immediate treatment and have a better quality of life while reducing health care costs.
read press release »
News Story Commentary By Academic and Community Oncologists
Learn more about the OBR training platform, developed to provide an in-depth understanding of the unique business dynamics of today's oncology landscape.
What clinical information presented at ASCO was of the most interest to oncologists?
To get a sense of the impact that the 2013 annual meeting of ASCO had on physicians, Encuity Research surveyed 100 oncologists who attended the event to see what they thought were the key themes and overall value of this year's meeting. Check out our blog to see the results of the survey.
OBR Job Board
Seattle GeneticsAdvocacy Development Director Advocacy Development Managers (4)
NovocureClinical Science Liaison Medical Communications Specialist Training Manager
Sarah CannonHome-based Clinical Research Associate